Metabolomic analysis of male combat veterans with post traumatic stress disorder

PLoS ONE

Volumn 14, Issue 3, 2019, Pages

  Mellon, Synthia H ^a   Bersani, F Saverio ^a,h   Lindqvist, Daniel ^a,i   Hammamieh, Rasha ^b   Donohue, Duncan ^b   Dean, Kelsey ^c   Jett, Marti ^b   Yehuda, Rachel ^d,e   Flory, Janine ^d,e   Reus, Victor I ^a   Bierer, Linda M ^d,e   Makotkine, Iouri ^d,e   Amara, Duna Abu ^f   Haase, Clare Henn ^f,j   Coy, Michelle ^a   Doyle, Francis J ^c   Marmar, Charles ^f,g   Wolkowitz, Owen M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b U S ARMY MEDICAL RESEARCH AND MATERIEL COMMAND   (United States)

^c HARVARD UNIVERSITY   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^f NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^h SAPIENZA UNIVERSITY OF ROME   (Italy)

ⁱ LUND UNIVERSITY   (Sweden)

^j NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTIDEPRESSANT AGENT; ANTIINFLAMMATORY AGENT; GLUCOSE; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; CARBOHYDRATE; FATTY ACID; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN; HYPOXANTHINE; LIPID;

ADULT; AFGHANISTAN; AMINO ACID METABOLISM; ARTICLE; BODY MASS; CASE CONTROL STUDY; COMORBIDITY; CONTROLLED STUDY; FATTY ACID METABOLISM; FATTY ACID TRANSPORT; GLUCOSE BLOOD LEVEL; GLYCOLYSIS; HUMAN; IRAQ; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MASS FRAGMENTOGRAPHY; METABOLOMICS; MITOCHONDRION; PATHOPHYSIOLOGY; PHENOTYPE; POSTTRAUMATIC STRESS DISORDER; SMOKING; TANDEM MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; VALIDATION STUDY; BLOOD; METABOLISM; PATHOLOGY; VETERAN;

ADULT; BODY MASS INDEX; CARBOHYDRATES; CASE-CONTROL STUDIES; FATTY ACIDS; GLYCATED HEMOGLOBIN A; HUMANS; HYPOXANTHINE; LIPIDS; MALE; METABOLOMICS; MITOCHONDRIA; STRESS DISORDERS, POST-TRAUMATIC; VETERANS;

EID: 85063274790     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0213839     Document Type: Article

References (161)

1. Levine AB, Levine LM, Levine TB. Posttraumatic stress disorder and cardiometabolic disease. Cardiology. 2014; 127(1):1–19. Epub 2013/10/26. https://doi.org/10.1159/000354910 PMID: 24157651.
2. Quinones MP, Kaddurah-Daouk R. Metabolomics tools for identifying biomarkers for neuropsychiatric diseases. Neurobiology of disease. 2009; 35(2):165–76. Epub 2009/03/24. https://doi.org/10.1016/j.nbd.2009.02.019 PMID: 19303440.
3. Rozen S, Cudkowicz ME, Bogdanov M, Matson WR, Kristal BS, Beecher C, et al. Metabolomic analysis and signatures in motor neuron disease. Metabolomics: Official journal of the Metabolomic Society. 2005; 1(2):101–8. Epub 2008/09/30. https://doi.org/10.1007/s11306-005-4810-1 PMID: 18820733; PubMed Central PMCID: PMC2553219.
4. Paige LA, Mitchell MW, Krishnan KR, Kaddurah-Daouk R, Steffens DC. A preliminary metabolomic analysis of older adults with and without depression. International journal of geriatric psychiatry. 2007; 22(5):418–23. Epub 2006/10/19. https://doi.org/10.1002/gps.1690 PMID: 17048218.
5. Holmes E, Tsang TM, Huang JT, Leweke FM, Koethe D, Gerth CW, et al. Metabolic profiling of CSF: evidence that early intervention may impact on disease progression and outcome in schizophrenia. PLoS medicine. 2006; 3(8):e327. Epub 2006/08/29. https://doi.org/10.1371/journal.pmed.0030327PMID: 16933966; PubMed Central PMCID: PMC1551919.
6. Kaddurah-Daouk R, McEvoy J, Baillie RA, Lee D, Yao JK, Doraiswamy PM, et al. Metabolomic mapping of atypical antipsychotic effects in schizophrenia. Molecular psychiatry. 2007; 12(10):934–45. Epub 2007/04/19. https://doi.org/10.1038/sj.mp.4002000 PMID: 17440431.
7. Han X, Rozen S, Boyle SH, Hellegers C, Cheng H, Burke JR, et al. Metabolomics in early Alzheimer’s disease: identification of altered plasma sphingolipidome using shotgun lipidomics. PloS one. 2011; 6 (7):e21643. Epub 2011/07/23. https://doi.org/10.1371/journal.pone.0021643 PMID: 21779331; PubMed Central PMCID: PMC3136924.
8. Kaddurah-Daouk R, Rozen S, Matson W, Han X, Hulette CM, Burke JR, et al. Metabolomic changes in autopsy-confirmed Alzheimer’s disease. Alzheimer’s & dementia: the journal of the Alzheimer’s Association. 2011; 7(3):309–17. Epub 2010/11/16. https://doi.org/10.1016/j.jalz.2010.06.001 PMID: 21075060; PubMed Central PMCID: PMC3061205.
9. Bogdanov M, Matson WR, Wang L, Matson T, Saunders-Pullman R, Bressman SS, et al. Metabolomic profiling to develop blood biomarkers for Parkinson’s disease. Brain: a journal of neurology. 2008; 131 (Pt 2):389–96. Epub 2008/01/29. https://doi.org/10.1093/brain/awm304 PMID: 18222993.
10. Underwood BR, Broadhurst D, Dunn WB, Ellis DI, Michell AW, Vacher C, et al. Huntington disease patients and transgenic mice have similar pro-catabolic serum metabolite profiles. Brain: a journal of neurology. 2006; 129(Pt 4):877–86. Epub 2006/02/09. https://doi.org/10.1093/brain/awl027 PMID: 16464959.
11. Koenig AM, Karabatsiakis A, Stoll T, Wilker S, Hennessy T, Hill MM, et al. Serum profile changes in postpartum women with a history of childhood maltreatment: a combined metabolite and lipid fingerprinting study. Sci Rep. 2018; 8(1):3468. https://doi.org/10.1038/s41598-018-21763-6 PMID: 29472571; PubMed Central PMCID: PMCPMC5823924.
12. Hadrevi J, Jonsdottir IH, Jansson PA, Eriksson JW, Sjors A. Plasma metabolomic patterns in patients with exhaustion disorder. Stress. 2018:1–10. https://doi.org/10.1080/10253890.2018.1494150 PMID: 30084722.
13. Brindle JT, Antti H, Holmes E, Tranter G, Nicholson JK, Bethell HW, et al. Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics. Nature medicine. 2002; 8(12):1439–44. Epub 2002/11/26. https://doi.org/10.1038/nm802 PMID: 12447357.
14. Sabatine MS, Liu E, Morrow DA, Heller E, McCarroll R, Wiegand R, et al. Metabolomic identification of novel biomarkers of myocardial ischemia. Circulation. 2005; 112(25):3868–75. Epub 2005/12/14. https://doi.org/10.1161/CIRCULATIONAHA.105.569137 PMID: 16344383.
15. Lu J, Xie G, Jia W, Jia W. Metabolomics in human type 2 diabetes research. Frontiers of medicine. 2013; 7(1):4–13. Epub 2013/02/05. https://doi.org/10.1007/s11684-013-0248-4 PMID: 23377891.
16. Milburn MV, Lawton KA. Application of metabolomics to diagnosis of insulin resistance. Annual review of medicine. 2013; 64:291–305. Epub 2013/01/19. https://doi.org/10.1146/annurev-med-061511-134747 PMID: 23327524.
17. Wang TJ, Larson MG, Vasan RS, Cheng S, Rhee EP, McCabe E, et al. Metabolite profiles and the risk of developing diabetes. Nature medicine. 2011; 17(4):448–53. Epub 2011/03/23. https://doi.org/10.1038/nm.2307 PMID: 21423183; PubMed Central PMCID: PMC3126616.
18. Karabatsiakis A, Hamuni G, Wilker S, Kolassa S, Renu D, Kadereit S, et al. Metabolite profiling in posttraumatic stress disorder. J Mol Psychiatry. 2015; 3(1):2. https://doi.org/10.1186/s40303-015-0007-3PMID: 25848535; PubMed Central PMCID: PMCPMC4367823.
19. Frayne SM, Chiu VY, Iqbal S, Berg EA, Laungani KJ, Cronkite RC, et al. Medical care needs of returning veterans with PTSD: their other burden. J Gen Intern Med. 2011; 26(1):33–9. https://doi.org/10.1007/s11606-010-1497-4 PMID: 20853066; PubMed Central PMCID: PMCPMC3024098.
20. Kao CY, He Z, Henes K, Asara JM, Webhofer C, Filiou MD, et al. Fluoxetine treatment rescues energy metabolism pathway alterations in a posttraumatic stress disorder mouse model. Mol Neuropsychiatry. 2016; 2(1):46–59. https://doi.org/10.1159/000445377 PMID: 27606320; PubMed Central PMCID: PMCPMC4996011.
21. Li XM, Han F, Liu DJ, Shi YX. Single-prolonged stress induced mitochondrial-dependent apoptosis in hippocampus in the rat model of post-traumatic stress disorder. Journal of chemical neuroanatomy. 2010; 40(3):248–55. Epub 2010/07/14. https://doi.org/10.1016/j.jchemneu.2010.07.001 PMID: 20624456.
22. Liu D, Xiao B, Han F, Wang E, Shi Y. Single-prolonged stress induces apoptosis in dorsal raphe nucleus in the rat model of posttraumatic stress disorder. BMC psychiatry. 2012; 12:211. Epub 2012/ 11/28. https://doi.org/10.1186/1471-244X-12-211 PMID: 23181934; PubMed Central PMCID: PMC3549289.
23. Li H, Li X, Smerin SE, Zhang L, Jia M, Xing G, et al. Mitochondrial Gene Expression Profiles and Metabolic Pathways in the Amygdala Associated with Exaggerated Fear in an Animal Model of PTSD. Front Neurol. 2014; 5:164. https://doi.org/10.3389/fneur.2014.00164 PMID: 25295026; PubMed Central PMCID: PMCPMC4172054.
24. Hammamieh R, Chakraborty N, Gautam A, Muhie S, Yang R, Donohue D, et al. Whole-genome DNA methylation status associated with clinical PTSD measures of OIF/OEF veterans. Transl Psychiatry. 2017; 7(7):e1169. https://doi.org/10.1038/tp.2017.129 PMID: 28696412; PubMed Central PMCID: PMCPMC5538114.
25. Su YA, Wu J, Zhang L, Zhang Q, Su DM, He P, et al. Dysregulated mitochondrial genes and networks with drug targets in postmortem brain of patients with posttraumatic stress disorder (PTSD) revealed by human mitochondria-focused cDNA microarrays. International journal of biological sciences. 2008; 4(4):223–35. Epub 2008/08/12. PMID: 18690294; PubMed Central PMCID: PMC2500154.
26. Zhang L, Hu XZ, Benedek DM, Fullerton CS, Forsten RD, Naifeh JA, et al. Dysregulated mitochondria-focused genes in US military service members with PTSD. European Journal of Psychotraumatol-ogy. 2012; 3. https://doi.org/10.3402/ejpt.v3i0.19309 WOS:000208868500178.
27. Boeck C, Koenig AM, Schury K, Geiger ML, Karabatsiakis A, Wilker S, et al. Inflammation in adult women with a history of child maltreatment: The involvement of mitochondrial alterations and oxidative stress. Mitochondrion. 2016; 30:197–207. https://doi.org/10.1016/j.mito.2016.08.006 PMID: 27530300.
28. Karabatsiakis A, Böck C, Salinas-Manrique J, Kolassa S, Calzia E, Dietrich DE, et al. Mitochondrial respiration in peripheral blood mononuclear cells correlates with depressive subsymptoms and severity of major depression. Transl Psychiatry. 2014; 4:e397.
29. Thakur GS, Daigle BJ Jr., Dean KR, Zhang Y, Rodriguez-Fernandez M, Hammamieh R, et al. Systems biology approach to understanding post-traumatic stress disorder. Mol Biosyst. 2015; 11(4):980–93. https://doi.org/10.1039/c4mb00404c PMID: 25627823.
30. Blake DD, Weathers FW, Nagy LM, Kaloupek DG, Gusman FD, Charney DS, et al. The development of a Clinician-Administered PTSD Scale. Journal of traumatic stress. 1995; 8(1):75–90. Epub 1995/01/ 01. PMID: 7712061.
31. Corrigan JD, Bogner J. Initial reliability and validity of the Ohio State University TBI Identification Method. The Journal of head trauma rehabilitation. 2007; 22(6):318–29. Epub 2007/11/21. https://doi.org/10.1097/01.HTR.0000300227.67748.77 PMID: 18025964.
32. First MB. Structured clinical interview for DSM-IV axis I disorders SCID-I: clinician version, administration booklet. Washington, DC: American Psychiatric Press; 1997.
33. Beck AT, Steer RA, Brown GK. Manual for Beck Depression Inventory-II. San Antonio, TX: Psychological Corporation; 1996.
34. Dehaven CD, Evans AM, Dai H, Lawton KA. Organization of GC/MS and LC/MS metabolomics data into chemical libraries. Journal of cheminformatics. 2010; 2(1):9. Epub 2010/10/20. https://doi.org/10.1186/1758-2946-2-9 PMID: 20955607; PubMed Central PMCID: PMC2984397.
35. Evans AM, DeHaven CD, Barrett T, Mitchell M, Milgram E. Integrated, nontargeted ultrahigh performance liquid chromatography/electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems. Analytical chemistry. 2009; 81(16):6656–67. Epub 2009/07/25. https://doi.org/10.1021/ac901536h PMID: 19624122.
36. Ohta T, Masutomi N, Tsutsui N, Sakairi T, Mitchell M, Milburn MV, et al. Untargeted metabolomic profiling as an evaluative tool of fenofibrate-induced toxicology in Fischer 344 male rats. Toxicologic pathology. 2009; 37(4):521–35. Epub 2009/05/22. https://doi.org/10.1177/0192623309336152 PMID: 19458390.
37. Blom G. Statistical estimates and transformed beta-variables. NY, NY: J. Wiley and Sons; 1958.
38. Storey JD, Tibshirani R. Statistical significance for genomewide studies. Proceedings of the National Academy of Sciences of the United States of America. 2003; 100(16):9440–5. Epub 2003/07/29. https://doi.org/10.1073/pnas.1530509100 PMID: 12883005; PubMed Central PMCID: PMC170937.
39. Hamer M, O’Donovan G, Stensel D, Stamatakis E. Normal-Weight Central Obesity and Risk for Mortality. Ann Intern Med. 2017; 166(12):917–8. https://doi.org/10.7326/L17-0022 PMID: 28437799.
40. Agarwal A, Banerjee A, Banerjee UC. Xanthine oxidoreductase: a journey from purine metabolism to cardiovascular excitation-contraction coupling. Crit Rev Biotechnol. 2011; 31(3):264–80. https://doi.org/10.3109/07388551.2010.527823 PMID: 21774633.
41. Blessing E, Reus VI, Mellon SH, Wolkowitz OM, Flory JD, Bierer LM, et al. Biological predictors of insulin resistance associated with posttraumatic stress disorder in young military veterans. Psychoneuroendocrinology. 2017; 82:91–7. https://doi.org/10.1016/j.psyneuen.2017.04.016 PMID: 28521179.
42. Association AP, editor. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington, VA: American Psychiatric Publishing; 2013.
43. O’Donovan A, Cohen BE, Seal KH, Bertenthal D, Margaretten M, Nishimi K, et al. Elevated risk for autoimmune disorders in iraq and afghanistan veterans with posttraumatic stress disorder. Biological psychiatry. 2015; 77(4):365–74. https://doi.org/10.1016/j.biopsych.2014.06.015 PMID: 25104173; PubMed Central PMCID: PMCPMC4277929.
44. Pacella ML, Hruska B, Delahanty DL. The physical health consequences of PTSD and PTSD symptoms: a meta-analytic review. J Anxiety Disord. 2013; 27(1):33–46. https://doi.org/10.1016/j.janxdis.2012.08.004 PMID: 23247200.
45. Wolf EJ, Schnurr PP. PTSD-Related Cardiovascular Disease and Accelerated Cellular Aging. Psychiatr Ann. 2016; 46:527–32. PMID: 27990033; PubMed Central PMCID: PMCPMC5154362.
46. Wolf EJ, Logue MW, Morrison FG, Wilcox ES, Stone A, Schichman SA, et al. Posttraumatic psychopathology and the pace of the epigenetic clock: a longitudinal investigation. Psychol Med. 2018:1–10. https://doi.org/10.1017/S0033291718001411 PMID: 29897034.
47. Mehta D, Bruenig D, Lawford B, Harvey W, Carrillo-Roa T, Morris CP, et al. Accelerated DNA methylation aging and increased resilience in veterans: The biological cost for soldiering on. Neurobiol Stress. 2018; 8:112–9. https://doi.org/10.1016/j.ynstr.2018.04.001 PMID: 29888306; PubMed Central PMCID: PMCPMC5991315.
48. Kuffer AL, O’Donovan A, Burri A, Maercker A. Posttraumatic Stress Disorder, Adverse Childhood Events, and Buccal Cell Telomere Length in Elderly Swiss Former Indentured Child Laborers. Front Psychiatry. 2016; 7:147. https://doi.org/10.3389/fpsyt.2016.00147 PMID: 27630582; PubMed Central PMCID: PMCPMC5005955.
49. Moreno-Villanueva M, Morath J, Vanhooren V, Elbert T, Kolassa S, Libert C, et al. N-glycosylation profiling of plasma provides evidence for accelerated physiological aging in post-traumatic stress disorder. Transl Psychiatry. 2013; 3:e320. https://doi.org/10.1038/tp.2013.93 PMID: 24169639; PubMed Central PMCID: PMCPMC3818009.
50. Roberts AL, Koenen KC, Chen Q, Gilsanz P, Mason SM, Prescott J, et al. Posttraumatic stress disorder and accelerated aging: PTSD and leukocyte telomere length in a sample of civilian women. Depression and anxiety. 2017; 34(5):391–400. https://doi.org/10.1002/da.22620 PMID: 28380289; PubMed Central PMCID: PMCPMC5848097.
51. Stein JY, Levin Y, Uziel O, Abumock H, Solomon Z. Traumatic stress and cellular senescence: The role of war-captivity and homecoming stressors in later life telomere length. J Affect Disord. 2018; 238:129–35. https://doi.org/10.1016/j.jad.2018.05.037 PMID: 29879607.
52. Wolf EJ, Maniates H, Nugent N, Maihofer AX, Armstrong D, Ratanatharathorn A, et al. Traumatic stress and accelerated DNA methylation age: A meta-analysis. Psychoneuroendocrinology. 2018; 92:123–34. https://doi.org/10.1016/j.psyneuen.2017.12.007 PMID: 29452766; PubMed Central PMCID: PMCPMC5924645.
53. Wolf EJ, Morrison FG. Traumatic Stress and Accelerated Cellular Aging: From Epigenetics to Cardio-metabolic Disease. Curr Psychiatry Rep. 2017; 19(10):75. https://doi.org/10.1007/s11920-017-0823-5PMID: 28852965; PubMed Central PMCID: PMCPMC5588711.
54. Zhang L, Hu XZ, Li X, Li H, Smerin S, Russell D, et al. Telomere length—a cellular aging marker for depression and Post-traumatic Stress Disorder. Medical hypotheses. 2014; 83(2):182–5. https://doi.org/10.1016/j.mehy.2014.04.033 PMID: 24875221.
55. Konjevod M, Tudor L, Svob Strac D, Nedic Erjavec G, Barbas C, Zarkovic N, et al. Metabolomic and glycomic findings in posttraumatic stress disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2019; 88:181–93. https://doi.org/10.1016/j.pnpbp.2018.07.014 PMID: 30025792.
56. Verhoeven JE, Yang R, Wolkowitz OM, Bersani FS, Lindqvist D, Mellon SH, et al. Epigenetic Age in Male Combat-Exposed War Veterans: Associations with Posttraumatic Stress Disorder Status. Molecular Neuropsychiatry. 2018; 4:102–11.
57. Gill J, Luckenbaugh D, Charney D, Vythilingam M. Sustained elevation of serum interleukin-6 and relative insensitivity to hydrocortisone differentiates posttraumatic stress disorder with and without depression. Biological psychiatry. 2010; 68(11):999–1006. https://doi.org/10.1016/j.biopsych.2010.07.033PMID: 20951370.
58. Pace TW, Heim CM. A short review on the psychoneuroimmunology of posttraumatic stress disorder: from risk factors to medical comorbidities. Brain, behavior, and immunity. 2011; 25(1):6–13. https://doi.org/10.1016/j.bbi.2010.10.003 PMID: 20934505.
59. Wheler GH, Brandon D, Clemons A, Riley C, Kendall J, Loriaux DL, et al. Cortisol production rate in posttraumatic stress disorder. The Journal of clinical endocrinology and metabolism. 2006; 91 (9):3486–9. Epub 2006/06/22. https://doi.org/10.1210/jc.2006-0061 PMID: 16787989.
60. Yehuda R, Bierer LM, Andrew R, Schmeidler J, Seckl JR. Enduring effects of severe developmental adversity, including nutritional deprivation, on cortisol metabolism in aging Holocaust survivors. Journal of psychiatric research. 2009; 43(9):877–83. Epub 2009/01/24. https://doi.org/10.1016/j.jpsychires.2008.12.003 PMID: 19162277; PubMed Central PMCID: PMC2749458.
61. Yehuda R, Bierer LM, Sarapas C, Makotkine I, Andrew R, Seckl JR. Cortisol metabolic predictors of response to psychotherapy for symptoms of PTSD in survivors of the World Trade Center attacks on September 11, 2001. Psychoneuroendocrinology. 2009; 34(9):1304–13. Epub 2009/05/05. https://doi.org/10.1016/j.psyneuen.2009.03.018 PMID: 19411143; PubMed Central PMCID: PMC2785023.
62. Michopoulos V, Vester A, Neigh G. Posttraumatic stress disorder: A metabolic disorder in disguise? Exp Neurol. 2016; 284(Pt B):220–9. https://doi.org/10.1016/j.expneurol.2016.05.038 PMID: 27246996; PubMed Central PMCID: PMCPMC5056806.
63. Rosenbaum S, Stubbs B, Ward PB, Steel Z, Lederman O, Vancampfort D. The prevalence and risk of metabolic syndrome and its components among people with posttraumatic stress disorder: a systematic review and meta-analysis. Metabolism: clinical and experimental. 2015; 64(8):926–33. https://doi.org/10.1016/j.metabol.2015.04.009 PMID: 25982700.
64. Gola H, Engler H, Sommershof A, Adenauer H, Kolassa S, Schedlowski M, et al. Posttraumatic stress disorder is associated with an enhanced spontaneous production of pro-inflammatory cytokines by peripheral blood mononuclear cells. BMC psychiatry. 2013; 13:40. https://doi.org/10.1186/1471-244X-13-40 PMID: 23360282; PubMed Central PMCID: PMCPMC3574862.
65. Passos IC, Vasconcelos-Moreno MP, Costa LG, Kunz M, Brietzke E, Quevedo J, et al. Inflammatory markers in post-traumatic stress disorder: a systematic review, meta-analysis, and meta-regression. Lancet Psychiatry. 2015; 2(11):1002–12. https://doi.org/10.1016/S2215-0366(15)00309-0 PMID: 26544749.
66. Wang Z, Mandel H, Levingston CA, Young MR. An exploratory approach demonstrating immune skewing and a loss of coordination among cytokines in plasma and saliva of Veterans with combat-related PTSD. Hum Immunol. 2016; 77(8):652–7. https://doi.org/10.1016/j.humimm.2016.05.018PMID: 27216157.
67. Wang Z, Young MR. PTSD, a Disorder with an Immunological Component. Front Immunol. 2016; 7:219. https://doi.org/10.3389/fimmu.2016.00219 PMID: 27375619; PubMed Central PMCID: PMCPMC4893499.
68. Bersani FS, Wolkowitz OM, Lindqvist D, Yehuda R, Flory J, Bierer LM, et al. Global arginine bioavail-ability, a marker of nitric oxide synthetic capacity, is decreased in PTSD and correlated with symptom severity and markers of inflammation. Brain, behavior, and immunity. 2016; 52:153–60. https://doi.org/10.1016/j.bbi.2015.10.015 PMID: 26515034.
69. Lindqvist D, Mellon SH, Dhabhar FS, Yehuda R, Marlene Grenon S, Flory JD, et al. Increased pro-inflammatory milieu in combat related PTSD—a new cohort replication study. Brain, behavior, and immunity. 2016. https://doi.org/10.1016/j.bbi.2016.09.012 PMID: 27638184.
70. Lindqvist D, Wolkowitz OM, Mellon S, Yehuda R, Flory JD, Henn-Haase C, et al. Proinflammatory milieu in combat-related PTSD is independent of depression and early life stress. Brain, behavior, and immunity. 2014; 42:81–8. Epub 2014/06/15. https://doi.org/10.1016/j.bbi.2014.06.003 PMID: 24929195.
71. Mellon SH, Gautam A, Hammamieh R, Jett M, Wolkowitz OM. Metabolism, Metabolomics, and Inflammation in Posttraumatic Stress Disorder. Biological psychiatry. 2018; 83(10):866–75. https://doi.org/10.1016/j.biopsych.2018.02.007 PMID: 29628193.
72. Zhang L, Zhou R, Li X, Ursano RJ, Li H. Stress-induced change of mitochondria membrane potential regulated by genomic and non-genomic GR signaling: a possible mechanism for hippocampus atrophy in PTSD. Medical hypotheses. 2006; 66(6):1205–8. https://doi.org/10.1016/j.mehy.2005.11.041 PMID: 16446049.
73. Xing G, Barry ES, Benford B, Grunberg NE, Li H, Watson WD, et al. Impact of repeated stress on traumatic brain injury-induced mitochondrial electron transport chain expression and behavioral responses in rats. Front Neurol. 2013; 4:196. https://doi.org/10.3389/fneur.2013.00196 PMID: 24376434; PubMed Central PMCID: PMCPMC3859919.
74. Naviaux RK. Metabolic features of the cell danger response. Mitochondrion. 2014; 16:7–17. Epub 2013/08/29. https://doi.org/10.1016/j.mito.2013.08.006 PMID: 23981537.
75. Amigo I, da Cunha FM, Forni MF, Garcia-Neto W, Kakimoto PA, Luevano-Martinez LA, et al. Mitochondrial form, function and signalling in aging. Biochem J. 2016; 473(20):3421–49. https://doi.org/10.1042/BCJ20160451 PMID: 27729586.
76. Bunkar N, Bhargava A, Khare NK, Mishra PK. Mitochondrial anomalies: driver to age associated degenerative human ailments. Front Biosci (Landmark Ed). 2016; 21:769–93. PMID: 26709805.
77. Morava E, Kozicz T. Mitochondria and the economy of stress (mal)adaptation. Neurosci Biobehav Rev. 2013; 37(4):668–80. https://doi.org/10.1016/j.neubiorev.2013.02.005 PMID: 23415702.
78. Tschopp J. Mitochondria: Sovereign of inflammation? Eur J Immunol. 2011; 41(5):1196–202. https://doi.org/10.1002/eji.201141436 PMID: 21469137.
79. Wentworth BA, Stein MB, Redwine LS, Xue Y, Taub PR, Clopton P, et al. Post-traumatic stress disorder: a fast track to premature cardiovascular disease? Cardiology in review. 2013; 21(1):16–22. Epub 2012/06/22. https://doi.org/10.1097/CRD.0b013e318265343b PMID: 22717656.
80. Maslov B, Marcinko D, Milicevic R, Babic D, Dordevic V, Jakovljevic M. Metabolic syndrome, anxiety, depression and suicidal tendencies in post-traumatic stress disorder and schizophrenic patients. Col-legium antropologicum. 2009; 33 Suppl 2:7–10. Epub 2010/02/03. PMID: 20120396.
81. Player MS, Peterson LE. Anxiety disorders, hypertension, and cardiovascular risk: a review. International journal of psychiatry in medicine. 2011; 41(4):365–77. Epub 2012/01/14. https://doi.org/10.2190/PM.41.4.f PMID: 22238841.
82. Jensen CF, Keller TW, Peskind ER, McFall ME, Veith RC, Martin D, et al. Behavioral and plasma cortisol responses to sodium lactate infusion in posttraumatic stress disorder. Annals of the New York Academy of Sciences. 1997; 821:444–8. Epub 1997/06/21. PMID: 9238226.
83. Jensen CF, Keller TW, Peskind ER, McFall ME, Veith RC, Martin D, et al. Behavioral and neuroendo-crine responses to sodium lactate infusion in subjects with posttraumatic stress disorder. The American journal of psychiatry. 1997; 154(2):266–8. Epub 1997/02/01. https://doi.org/10.1176/ajp.154.2. 266 PMID: 9016280.
84. Jensen CF, Peskind ER, Keller TW, McFall ME, Raskind MA. Comparison of sodium lactate-induced panic symptoms between panic disorder and posttraumatic stress disorder. Depression and anxiety. 1998; 7(3):122–5. Epub 1998/07/10. PMID: 9656092.
85. Knox D, Perrine SA, George SA, Galloway MP, Liberzon I. Single prolonged stress decreases glutamate, glutamine, and creatine concentrations in the rat medial prefrontal cortex. Neuroscience letters. 2010; 480(1):16–20. Epub 2010/06/16. https://doi.org/10.1016/j.neulet.2010.05.052 PMID: 20546834; PubMed Central PMCID: PMC2902659.
86. Maddock RJ, Buonocore MH. MR Spectroscopic Studies of the Brain in Psychiatric Disorders. Current topics in behavioral neurosciences. 2012. Epub 2012/02/02. https://doi.org/10.1007/7854_2011_197PMID: 22294088.
87. Muhtz C, Wiedemann K, Kellner M. Panicogens in patients with Post-Traumatic Stress Disorder (PTSD). Current pharmaceutical design. 2012; 18(35):5608–18. Epub 2012/05/29. PMID: 22632476.
88. Perry D. 1st International Conference on Panic Attacks: diversity of theories and treatments. September 5–8, 2003, London. Expert opinion on pharmacotherapy. 2004; 5(4):977–80. Epub 2004/04/23. https://doi.org/10.1517/14656566.5.4.977 PMID: 15102580.
89. Rainey JM Jr., Aleem A, Ortiz A, Yeragani V, Pohl R, Berchou R. A laboratory procedure for the induction of flashbacks. The American journal of psychiatry. 1987; 144(10):1317–9. Epub 1987/10/01. https://doi.org/10.1176/ajp.144.10.1317 PMID: 3661765.
90. Stehberg J, Moraga-Amaro R, Salazar C, Becerra A, Echeverria C, Orellana JA, et al. Release of glio-transmitters through astroglial connexin 43 hemichannels is necessary for fear memory consolidation in the basolateral amygdala. FASEB journal: official publication of the Federation of American Societies for Experimental Biology. 2012; 26(9):3649–57. Epub 2012/06/06. https://doi.org/10.1096/fj.11-198416 PMID: 22665389.
91. Strohle A, Holsboer F. Stress responsive neurohormones in depression and anxiety. Pharmacopsy-chiatry. 2003; 36 Suppl 3:S207–14. Epub 2003/12/17. https://doi.org/10.1055/s-2003-45132 PMID: 14677081.
92. Maddock RJ, Buonocore MH, Copeland LE, Richards AL. Elevated brain lactate responses to neural activation in panic disorder: a dynamic 1H-MRS study. Molecular psychiatry. 2009; 14(5):537–45. Epub 2008/01/09. https://doi.org/10.1038/sj.mp.4002137 PMID: 18180759.
93. Cai TQ, Ren N, Jin L, Cheng K, Kash S, Chen R, et al. Role of GPR81 in lactate-mediated reduction of adipose lipolysis. Biochemical and biophysical research communications. 2008; 377(3):987–91. Epub 2008/10/28. https://doi.org/10.1016/j.bbrc.2008.10.088 PMID: 18952058.
94. Ahmed K, Tunaru S, Langhans CD, Hanson J, Michalski CW, Kolker S, et al. Deorphanization of GPR109B as a receptor for the beta-oxidation intermediate 3-OH-octanoic acid and its role in the regulation of lipolysis. The Journal of biological chemistry. 2009; 284(33):21928–33. Epub 2009/06/30. https://doi.org/10.1074/jbc.M109.019455 PMID: 19561068; PubMed Central PMCID: PMC2755917.
95. Ahmed K, Tunaru S, Offermanns S. GPR109A, GPR109B and GPR81, a family of hydroxy-carboxylic acid receptors. Trends in pharmacological sciences. 2009; 30(11):557–62. Epub 2009/10/20. https://doi.org/10.1016/j.tips.2009.09.001 PMID: 19837462.
96. Ahmed K, Tunaru S, Tang C, Muller M, Gille A, Sassmann A, et al. An autocrine lactate loop mediates insulin-dependent inhibition of lipolysis through GPR81. Cell metabolism. 2010; 11(4):311–9. Epub 2010/04/09. https://doi.org/10.1016/j.cmet.2010.02.012 PMID: 20374963.
97. Liu C, Wu J, Zhu J, Kuei C, Yu J, Shelton J, et al. Lactate inhibits lipolysis in fat cells through activation of an orphan G-protein-coupled receptor, GPR81. The Journal of biological chemistry. 2009; 284 (5):2811–22. Epub 2008/12/03. https://doi.org/10.1074/jbc.M806409200 PMID: 19047060.
98. Lovejoy J, Newby FD, Gebhart SS, DiGirolamo M. Insulin resistance in obesity is associated with elevated basal lactate levels and diminished lactate appearance following intravenous glucose and insulin. Metabolism: clinical and experimental. 1992; 41(1):22–7. Epub 1992/01/01. PMID: 1538640.
99. Lovejoy J, Mellen B, Digirolamo M. Lactate generation following glucose ingestion: relation to obesity, carbohydrate tolerance and insulin sensitivity. International journal of obesity. 1990; 14(10):843–55. Epub 1990/10/01. PMID: 2269580.
100. Pearce FJ, Connett RJ. Effect of lactate and palmitate on substrate utilization of isolated rat soleus. The American journal of physiology. 1980; 238(5):C149–59. Epub 1980/05/01. https://doi.org/10.1152/ajpcell.1980.238.5.C149 PMID: 6990780.
101. Clark AS, Mitch WE, Goodman MN, Fagan JM, Goheer MA, Curnow RT. Dichloroacetate inhibits glycolysis and augments insulin-stimulated glycogen synthesis in rat muscle. The Journal of clinical investigation. 1987; 79(2):588–94. Epub 1987/02/01. https://doi.org/10.1172/JCI112851 PMID: 3543056; PubMed Central PMCID: PMC424134.
102. Fisher AB, Dodia C. Lactate and regulation of lung glycolytic rate. The American journal of physiology. 1984; 246(5 Pt 1):E426–9. Epub 1984/05/01. https://doi.org/10.1152/ajpendo.1984.246.5.E426PMID: 6720945.
103. Lauritzen F, Eid T, Bergersen LH. Monocarboxylate transporters in temporal lobe epilepsy: roles of lactate and ketogenic diet. Brain structure & function. 2013. Epub 2013/11/20. https://doi.org/10.1007/ s00429-013-0672-x PMID: 24248427.
104. Lauritzen KH, Morland C, Puchades M, Holm-Hansen S, Hagelin EM, Lauritzen F, et al. Lactate Receptor Sites Link Neurotransmission, Neurovascular Coupling, and Brain Energy Metabolism. Cereb Cortex. 2013. Epub 2013/05/23. https://doi.org/10.1093/cercor/bht136 PMID: 23696276.
105. Bergersen LH, Gjedde A. Is lactate a volume transmitter of metabolic states of the brain? Frontiers in neuroenergetics. 2012; 4:5. Epub 2012/03/30. https://doi.org/10.3389/fnene.2012.00005 PMID: 22457647; PubMed Central PMCID: PMC3307048.
106. Bergold PJ, Pinkhasova V, Syed M, Kao HY, Jozwicka A, Zhao N, et al. Production of panic-like symptoms by lactate is associated with increased neural firing and oxidation of brain redox in the rat hippocampus. Neuroscience letters. 2009; 453(3):219–24. Epub 2009/05/12. https://doi.org/10.1016/j.neulet.2009.02.041 PMID: 19429039.
107. von Pfostl V, Li J, Zaldivar D, Goense J, Zhang X, Serr N, et al. Effects of lactate on the early visual cortex of non-human primates, investigated by pharmaco-MRI and neurochemical analysis. Neuro-Image. 2012; 61(1):98–105. Epub 2012/03/20. https://doi.org/10.1016/j.neuroimage.2012.02.082PMID: 22426350.
108. Yang J, Ruchti E, Petit JM, Jourdain P, Grenningloh G, Allaman I, et al. Lactate promotes plasticity gene expression by potentiating NMDA signaling in neurons. Proceedings of the National Academy of Sciences of the United States of America. 2014; 111(33):12228–33. Epub 2014/07/30. https://doi.org/10.1073/pnas.1322912111 PMID: 25071212; PubMed Central PMCID: PMC4143009.
109. Bozzo L, Puyal J, Chatton JY. Lactate modulates the activity of primary cortical neurons through a receptor-mediated pathway. PloS one. 2013; 8(8):e71721. Epub 2013/08/21. https://doi.org/10.1371/journal.pone.0071721 PMID: 23951229; PubMed Central PMCID: PMC3741165.
110. Zhao X, Cho H, Yu RT, Atkins AR, Downes M, Evans RM. Nuclear receptors rock around the clock. EMBO Rep. 2014; 15(5):518–28. https://doi.org/10.1002/embr.201338271 PMID: 24737872; PubMed Central PMCID: PMCPMC4210094.
111. Koffel E, Khawaja IS, Germain A. Sleep Disturbances in Posttraumatic Stress Disorder: Updated Review and Implications for Treatment. Psychiatr Ann. 2016; 46(3):173–6. https://doi.org/10.3928/ 00485713-20160125-01 PMID: 27773950; PubMed Central PMCID: PMCPMC5068571.
112. Nader N, Chrousos GP, Kino T. Circadian rhythm transcription factor CLOCK regulates the transcriptional activity of the glucocorticoid receptor by acetylating its hinge region lysine cluster: potential physiological implications. FASEB journal: official publication of the Federation of American Societies for Experimental Biology. 2009; 23(5):1572–83. https://doi.org/10.1096/fj.08-117697 PMID: 19141540; PubMed Central PMCID: PMCPMC2669420.
113. Meijer K, de Vos P, Priebe MG. Butyrate and other short-chain fatty acids as modulators of immunity: what relevance for health? Current opinion in clinical nutrition and metabolic care. 2010; 13(6):715–21. Epub 2010/09/09. https://doi.org/10.1097/MCO.0b013e32833eebe5 PMID: 20823773.
114. Baker RG, Hayden MS, Ghosh S. NF-kappaB, inflammation, and metabolic disease. Cell metabolism. 2011; 13(1):11–22. Epub 2011/01/05. https://doi.org/10.1016/j.cmet.2010.12.008 PMID: 21195345; PubMed Central PMCID: PMC3040418.
115. Ahmadian M, Suh JM, Hah N, Liddle C, Atkins AR, Downes M, et al. PPARgamma signaling and metabolism: the good, the bad and the future. Nature medicine. 2013; 19(5):557–66. Epub 2013/05/ 09. https://doi.org/10.1038/nm.3159 PMID: 23652116; PubMed Central PMCID: PMC3870016.
116. Duplus E, Forest C. Is there a single mechanism for fatty acid regulation of gene transcription? Biochemical pharmacology. 2002; 64(5–6):893–901. Epub 2002/09/06. PMID: 12213584.
117. Clarke SD. The multi-dimensional regulation of gene expression by fatty acids: polyunsaturated fats as nutrient sensors. Current opinion in lipidology. 2004; 15(1):13–8. Epub 2004/05/29. PMID: 15166803.
118. Jump DB. Fatty acid regulation of gene transcription. Critical reviews in clinical laboratory sciences. 2004; 41(1):41–78. Epub 2004/04/14. https://doi.org/10.1080/10408360490278341 PMID: 15077723.
119. Lapillonne A, Clarke SD, Heird WC. Polyunsaturated fatty acids and gene expression. Current opinion in clinical nutrition and metabolic care. 2004; 7(2):151–6. Epub 2004/04/13. PMID: 15075705.
120. Hirasawa A, Tsumaya K, Awaji T, Katsuma S, Adachi T, Yamada M, et al. Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120. Nature medicine. 2005; 11(1):90–4. Epub 2004/12/28. https://doi.org/10.1038/nm1168 PMID: 15619630.
121. Oh DY, Talukdar S, Bae EJ, Imamura T, Morinaga H, Fan W, et al. GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell. 2010; 142(5):687–98. Epub 2010/09/04. https://doi.org/10.1016/j.cell.2010.07.041 PMID: 20813258; PubMed Central PMCID: PMC2956412.
122. Oh da Y, Walenta E, Akiyama TE, Lagakos WS, Lackey D, Pessentheiner AR, et al. A Gpr120-selec-tive agonist improves insulin resistance and chronic inflammation in obese mice. Nature medicine. 2014; 20(8):942–7. Epub 2014/07/07. https://doi.org/10.1038/nm.3614 PMID: 24997608; PubMed Central PMCID: PMC4126875.
123. Janssen CI, Kiliaan AJ. Long-chain polyunsaturated fatty acids (LCPUFA) from genesis to senescence: the influence of LCPUFA on neural development, aging, and neurodegeneration. Progress in lipid research. 2014; 53:1–17. Epub 2013/12/18. https://doi.org/10.1016/j.plipres.2013.10.002 PMID: 24334113.
124. McNamara RK, Strawn JR. Role of Long-Chain Omega-3 Fatty Acids in Psychiatric Practice. Pharma-Nutrition. 2013; 1(2):41–9. Epub 2013/04/23. https://doi.org/10.1016/j.phanu.2012.10.004 PMID: 23607087; PubMed Central PMCID: PMC3628733.
125. Milte CM, Parletta N, Buckley JD, Coates AM, Young RM, Howe PR. Increased Erythrocyte Eicosa-pentaenoic Acid and Docosahexaenoic Acid Are Associated With Improved Attention and Behavior in Children With ADHD in a Randomized Controlled Three-Way Crossover Trial. Journal of attention disorders. 2013. Epub 2013/11/12. https://doi.org/10.1177/1087054713510562 PMID: 24214970.
126. Grosso G, Galvano F, Marventano S, Malaguarnera M, Bucolo C, Drago F, et al. Omega-3 fatty acids and depression: scientific evidence and biological mechanisms. Oxidative medicine and cellular longevity. 2014; 2014:313570. Epub 2014/04/24. https://doi.org/10.1155/2014/313570 PMID: 24757497; PubMed Central PMCID: PMC3976923.
127. Grosso G, Pajak A, Marventano S, Castellano S, Galvano F, Bucolo C, et al. Role of omega-3 Fatty acids in the treatment of depressive disorders: a comprehensive meta-analysis of randomized clinical trials. PloS one. 2014; 9(5):e96905. Epub 2014/05/09. https://doi.org/10.1371/journal.pone.0096905PMID: 24805797; PubMed Central PMCID: PMC4013121.
128. Hammamieh R, Chakraborty N, Gautam A, Miller SA, Muhie S, Meyerhoff J, et al. Transcriptomic analysis of the effects of a fish oil enriched diet on murine brains. PloS one. 2014; 9(3):e90425. Epub 2014/03/19. https://doi.org/10.1371/journal.pone.0090425 PMID: 24632812; PubMed Central PMCID: PMC3954562.
129. Zugno AI, Chipindo HL, Volpato AM, Budni J, Steckert AV, de Oliveira MB, et al. Omega-3 prevents behavior response and brain oxidative damage in the ketamine model of schizophrenia. Neuroscience. 2014; 259:223–31. Epub 2013/12/10. https://doi.org/10.1016/j.neuroscience.2013.11.049PMID: 24316471.
130. Fedorova I, Hussein N, Baumann MH, Di Martino C, Salem N Jr. An n-3 fatty acid deficiency impairs rat spatial learning in the Barnes maze. Behavioral neuroscience. 2009; 123(1):196–205. Epub 2009/ 01/28. https://doi.org/10.1037/a0013801 PMID: 19170444.
131. Chalon S. Omega-3 fatty acids and monoamine neurotransmission. Prostaglandins, leukotrienes, and essential fatty acids. 2006; 75(4–5):259–69. Epub 2006/09/12. https://doi.org/10.1016/j.plefa.2006.07.005 PMID: 16963244.
132. Bourre JM, Pascal G, Durand G, Masson M, Dumont O, Piciotti M. Alterations in the fatty acid composition of rat brain cells (neurons, astrocytes, and oligodendrocytes) and of subcellular fractions (myelin and synaptosomes) induced by a diet devoid of n-3 fatty acids. Journal of neurochemistry. 1984; 43 (2):342–8. Epub 1984/08/01. PMID: 6736955.
133. Moriguchi T, Salem N Jr. Recovery of brain docosahexaenoate leads to recovery of spatial task performance. Journal of neurochemistry. 2003; 87(2):297–309. Epub 2003/09/27. PMID: 14511107.
134. Levant B, Radel JD, Carlson SE. Decreased brain docosahexaenoic acid during development alters dopamine-related behaviors in adult rats that are differentially affected by dietary remediation. Beha-vioural brain research. 2004; 152(1):49–57. Epub 2004/05/12. https://doi.org/10.1016/j.bbr.2003.09. 029 PMID: 15135968.
135. Chuang JC, Cui H, Mason BL, Mahgoub M, Bookout AL, Yu HG, et al. Chronic social defeat stress disrupts regulation of lipid synthesis. Journal of lipid research. 2010; 51(6):1344–53. Epub 2010/02/05. https://doi.org/10.1194/jlr.M002196 PMID: 20129912; PubMed Central PMCID: PMC3035497.
136. Gautam A, D’Arpa P, Donohue DE, Muhie S, Chakraborty N, Luke BT, et al. Acute and chronic plasma metabolomic and liver transcriptomic stress effects in a mouse model with features of post-traumatic stress disorder. PloS one. 2015; 10(1):e0117092. Epub 2015/01/30. https://doi.org/10.1371/journal.pone.0117092 PMID: 25629821.
137. Muskiet FAJ. Pathophysiology and Evolutionary Aspects of Dietary Fats and Long-Chain Polyunsaturated Fatty Acids across the Life Cycle. In: Montmayeur JP, le Coutre J, editors. Fat Detection: Taste, Texture, and Post Ingestive Effects. Frontiers in Neuroscience. Boca Raton (FL)2010.
138. Matsumura K, Noguchi H, Nishi D, Matsuoka Y. The effect of omega-3 fatty acids on psychophysiological assessment for the secondary prevention of posttraumatic stress disorder: an open-label pilot study. Global journal of health science. 2012; 4(1):3–9. Epub 2012/09/18. https://doi.org/10.5539/gjhs. v4n1p3 PMID: 22980098.
139. Matsuoka Y, Nishi D, Yonemoto N, Hamazaki K, Matsumura K, Noguchi H, et al. Tachikawa project for prevention of posttraumatic stress disorder with polyunsaturated fatty acid (TPOP): study protocol for a randomized controlled trial. BMC psychiatry. 2013; 13:8. Epub 2013/01/08. https://doi.org/10.1186/1471-244X-13-8 PMID: 23289548; PubMed Central PMCID: PMC3598223.
140. Rodrigues AF, Roecker R, Junges GM, de Lima DD, da Cruz JG, Wyse AT, et al. Hypoxanthine induces oxidative stress in kidney of rats: protective effect of vitamins E plus C and allopurinol. Cell Biochem Funct. 2014; 32(4):387–94. https://doi.org/10.1002/cbf.3029 PMID: 24578313.
141. Mesquita Casagrande AC, Wamser MN, de Lima DD, Pereira da Cruz JG, Wyse AT, Dal Magro DD. In vitro stimulation of oxidative stress by hypoxanthine in blood of rats: prevention by vitamins e plus C and allopurinol. Nucleosides Nucleotides Nucleic Acids. 2013; 32(1):42–57. https://doi.org/10.1080/15257770.2012.760043 PMID: 23360294.
142. Puurunen J, Tiira K, Lehtonen M, Hanhineva K, Lohi H. Non-targeted metabolite profiling reveals changes in oxidative stress, tryptophan and lipid metabolisms in fearful dogs. Behav Brain Funct. 2016; 12(1):7. https://doi.org/10.1186/s12993-016-0091-2 PMID: 26867941; PubMed Central PMCID: PMCPMC4751666.
143. Su ZH, Li SQ, Zou GA, Yu CY, Sun YG, Zhang HW, et al. Urinary metabonomics study of anti-depressive effect of Chaihu-Shu-Gan-San on an experimental model of depression induced by chronic variable stress in rats. J Pharm Biomed Anal. 2011; 55(3):533–9. https://doi.org/10.1016/j.jpba.2011.02. 013 PMID: 21398066.
144. Chang SJ, Chen SM, Chiang SL, Chang KL, Ko YC. Association between cigarette smoking and hypoxanthine guanine phosphoribosyltransferase activity. Kaohsiung J Med Sci. 2005; 21(11):495–501. https://doi.org/10.1016/S1607-551X(09)70157-3 PMID: 16358551.
145. Yamamoto T, Moriwaki Y, Takahashi S. Effect of ethanol on metabolism of purine bases (hypoxanthine, xanthine, and uric acid). Clin Chim Acta. 2005; 356(1–2):35–57. https://doi.org/10.1016/j.cccn.2005.01.024 PMID: 15936302.
146. Ryu HM, Kim YJ, Oh EJ, Oh SH, Choi JY, Cho JH, et al. Hypoxanthine induces cholesterol accumulation and incites atherosclerosis in apolipoprotein E-deficient mice and cells. J Cell Mol Med. 2016. https://doi.org/10.1111/jcmm.12916 PMID: 27396856.
147. Lewis GD, Wei R, Liu E, Yang E, Shi X, Martinovic M, et al. Metabolite profiling of blood from individuals undergoing planned myocardial infarction reveals early markers of myocardial injury. The Journal of clinical investigation. 2008; 118(10):3503–12. https://doi.org/10.1172/JCI35111 PMID: 18769631; PubMed Central PMCID: PMCPMC2525696.
148. Moseley HN. Error Analysis and Propagation in Metabolomics Data Analysis. Comput Struct Biotechnol J. 2013; 4(5). https://doi.org/10.5936/csbj.201301006 PMID: 23667718; PubMed Central PMCID: PMCPMC3647477.
149. Tzoulaki I, Ebbels TM, Valdes A, Elliott P, Ioannidis JP. Design and analysis of metabolomics studies in epidemiologic research: a primer on -omic technologies. Am J Epidemiol. 2014; 180(2):129–39. https://doi.org/10.1093/aje/kwu143 PMID: 24966222.
150. Li SH, Graham BM. Why are women so vulnerable to anxiety, trauma-related and stress-related disorders? The potential role of sex hormones. Lancet Psychiatry. 2017; 4(1):73–82. https://doi.org/10.1016/S2215-0366(16)30358-3 PMID: 27856395.
151. Shah SH, Kraus WE, Newgard CB. Metabolomic profiling for the identification of novel biomarkers and mechanisms related to common cardiovascular diseases: form and function. Circulation. 2012; 126 (9):1110–20. Epub 2012/08/29. https://doi.org/10.1161/CIRCULATIONAHA.111.060368 PMID: 22927473.
152. Mapstone M, Cheema AK, Fiandaca MS, Zhong X, Mhyre TR, Macarthur LH, et al. Plasma phospholipids identify antecedent memory impairment in older adults. Nature medicine. 2014; 20(4):415–8. https://doi.org/10.1038/nm.3466 PMID: 24608097; PubMed Central PMCID: PMCPMC5360460.
153. Noga MJ, Dane A, Shi S, Attali A, van Aken H, Suidgeest E, et al. Metabolomics of cerebrospinal fluid reveals changes in the central nervous system metabolism in a rat model of multiple sclerosis. Metabolomics: Official journal of the Metabolomic Society. 2012; 8(2):253–63. Epub 2012/03/27. https://doi.org/10.1007/s11306-011-0306-3 PMID: 22448154; PubMed Central PMCID: PMC3291832.
154. Cuthbert BN, Insel TR. Toward the future of psychiatric diagnosis: the seven pillars of RDoC. BMC medicine. 2013; 11:126. https://doi.org/10.1186/1741-7015-11-126 PMID: 23672542; PubMed Central PMCID: PMCPMC3653747.
155. Stein JY, Wilmot DV, Solomon Z. Does one size fit all? Nosological, clinical, and scientific implications of variations in PTSD Criterion A. J Anxiety Disord. 2016; 43:106–17. https://doi.org/10.1016/j.janxdis.2016.07.001 PMID: 27449856.
156. Valero T. Mitochondrial biogenesis: pharmacological approaches. Current pharmaceutical design. 2014; 20(35):5507–9. PMID: 24606795.
157. Chiang MC, Chern Y, Huang RN. PPARgamma rescue of the mitochondrial dysfunction in Huntington’s disease. Neurobiology of disease. 2012; 45(1):322–8. Epub 2011/09/13. https://doi.org/10.1016/j.nbd.2011.08.016 PMID: 21907283.
158. Mortiboys H, Aasly J, Bandmann O. Ursocholanic acid rescues mitochondrial function in common forms of familial Parkinson’s disease. Brain: a journal of neurology. 2013; 136(Pt 10):3038–50. Epub 2013/09/04. https://doi.org/10.1093/brain/awt224 PMID: 24000005.
159. Valaasani KR, Sun Q, Hu G, Li J, Du F, Guo Y, et al. Identification of human ABAD inhibitors for rescuing Abeta-mediated mitochondrial dysfunction. Current Alzheimer research. 2014; 11(2):128–36. Epub 2014/02/01. PMID: 24479630; PubMed Central PMCID: PMC4082996.
160. Chen WW, Birsoy K, Mihaylova MM, Snitkin H, Stasinski I, Yucel B, et al. Inhibition of ATPIF1 ameliorates severe mitochondrial respiratory chain dysfunction in mammalian cells. Cell reports. 2014; 7 (1):27–34. Epub 2014/04/02. https://doi.org/10.1016/j.celrep.2014.02.046 PMID: 24685140; PubMed Central PMCID: PMC4040975.
161. Ipser JC, Stein DJ. Evidence-based pharmacotherapy of post-traumatic stress disorder (PTSD). Int J Neuropsychopharmacol. 2012; 15(6):825–40. https://doi.org/10.1017/S1461145711001209 PMID: 21798109.